INTERNATIONAL PATENT: PHRONTLINE BIOPHARMA (SUZHOU) CO., LTD, 拓济医药（苏州）有限责任公司, SHANGHAI PHRONTLINE BIOPHARMA CO., LTD, 上海拓济医药有限责任公司 FILES APPLICATION FOR "FC REGION-BASED HETERODIMER MOLECULE AND USE THEREOF"

Posted On: 2025-05-11

GENEVA, May 11 -- PHRONTLINE BIOPHARMA (SUZHOU) CO., LTD (Room 1915, Building 1, Tianyun Square, No. 111 Wusongjiang Ave., Wuzhong DistrictSuzhou, Jiangsu 215124), 拓济医药（苏州）有限责任公司 (中国江苏省苏州市吴中区郭巷街道吴淞江大道111号天运广场1幢1号楼19层1915室), SHANGHAI PHRONTLINE BIOPHARMA CO., LTD (Room 301, Building 2, No. 396 Lishizhen Rd., Free Trade ZonePudong New Area, Shanghai 201203), 上海拓济医药有限责任...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: PHRONTLINE BIOPHARMA (SUZHOU) CO., LTD, 拓济医药（苏州）有限责任公司, SHANGHAI PHRONTLINE BIOPHARMA CO., LTD, 上海拓济医药有限责任公司 FILES APPLICATION FOR "FC REGION-BASED HETERODIMER MOLECULE AND USE THEREOF"